zalcitabine has been researched along with nsc 614846 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, M; Vince, R | 1 |
| Cameron, JM; Coates, JA; Inggall, HJ; Pearson, BA; Penn, CR; Storer, R; Williamson, C | 1 |
| Brownell, J; Daluge, S; Hua, M; Kiser, R; Lavelle, GC; Lee, FC; Qualls, J; Shannon, WM; Vince, R; Weislow, OS | 1 |
| Evans, GL; Harker, AJ; Hawley, AE; Morris, DM | 1 |
| Bennett, LL; Parker, WB; Shaddix, SC; Vince, R | 1 |
5 other study(ies) available for zalcitabine and nsc 614846
| Article | Year |
|---|---|
Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosides.
Topics: Animals; Antiviral Agents; Chemical Phenomena; Chemistry; Cytopathogenic Effect, Viral; Dideoxyadenosine; Dideoxynucleosides; HIV; Leukemia P388; Molecular Structure; Purine Nucleosides; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication; Zidovudine | 1990 |
Carbovir: the (-) enantiomer is a potent and selective antiviral agent against human immunodeficiency virus in vitro.
Topics: CD4-Positive T-Lymphocytes; Cell Line; Cell Survival; Dideoxynucleosides; Giant Cells; HIV; Humans; Viral Core Proteins; Virus Replication; Zalcitabine; Zidovudine | 1991 |
Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytopathogenic Effect, Viral; Dideoxynucleosides; HIV; Molecular Structure; Structure-Activity Relationship; Virus Replication; Zalcitabine; Zidovudine | 1988 |
High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
Topics: Antiviral Agents; Autoanalysis; Chromatography, High Pressure Liquid; Dideoxynucleosides; HIV Seropositivity; Hot Temperature; Humans; Lamivudine; Quality Control; Sensitivity and Specificity; Zalcitabine | 1994 |
Lack of mitochondrial toxicity in CEM cells treated with carbovir.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cell Line; Dideoxynucleosides; DNA, Mitochondrial; Drug Evaluation, Preclinical; Humans; Lactic Acid; Mitochondria; Prodrugs; Zalcitabine | 1997 |